Add AGU Calls
Counteract CF with AGU Upside Play
PLAY: Buy the AGU April 70 Calls (O:AGU 10D70.00) at or under $2.90, good for the day. Place a protective stop limit at $2.20 and a pre-determined sniper sell at $4.50.
Dear Bottarelli Research Member,
Let’s go ahead and counteract our latest CF put play with an upside call position on Agrium (AGU – NYSE). As you know, the entire “fertilizer war” situation ended up with CF overpaying for Terra (thus diluting CF shareholders), while AGU came out looking like the winner. This could help AGU push higher in the coming days, especially as it dips down to a strong level of support at $69.00. Let’s get positioned to ride the next up-wave now!
PLAY: Buy the AGU April 70 Calls (O:AGU 10D70.00) at or under $2.90, good for the day. Place a protective stop limit at $2.20 and a pre-determined sniper sell at $4.50.
And as always…
Lock and load!
Sincerely,
© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.